Trail Evaluating Particle Therapy With or Without Apatinib for H&N Adenoid Cystic Carcinoma
A Phase II Randomized Trial of Efficacy and Safety of Particle Therapy With or Without Apatinib as Induction Therapy for Treatment of Head and Neck Adenoid Cystic Carcinoma
Sponsor: Shanghai Proton and Heavy Ion Center
Listed as NCT02942693, this PHASE2 trial focuses on Adenoid Cystic Carcinoma and remains ongoing. Sponsored by Shanghai Proton and Heavy Ion Center, it has been updated 7 times since 2016, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE2
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE2
-
Sep 2020 — Jan 2021 [monthly]
Unknown Status PHASE2
Status: Recruiting → Unknown Status
-
Oct 2018 — Sep 2020 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
▶ Show 2 earlier versions
-
Jun 2018 — Oct 2018 [monthly]
Not Yet Recruiting PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Not Yet Recruiting PHASE2
First recorded
Nov 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Shanghai Proton and Heavy Ion Center
For direct contact, visit the study record on ClinicalTrials.gov .